An application on breast cancer life insurance and critical illness insurance
Duration of the Project: 2022 – 2023 (currently underway)
The project is led by Heriot-Watt University and primarily managed by Arık Ayşe, Department of Actuarial Mathematics and Statistics, Heriot-Watt University, and the Maxwell Institute for Mathematical Sciences, UK, Research Fellow with support from Streftaris George, Department of Actuarial Mathematics and Statistics, Heriot-Watt University, and the Maxwell Institute for Mathematical Sciences, UK, Professor of Statistics.
The project is associated with ongoing research focusing on results dissemination, knowledge exchange, and conference presentations.
Steering committee
Foundation: Zeying Peuillet and Adam Shao
Heriot-Watt University: Ayse Arik and George Streftaris
The main objectives of the related research project are to:
- investigating how the COVID-19 pandemic, and its impact on the diagnosis of different stages of breast cancer (BC) morbidity, have affected BC mortality;
- assessing the implications of COVID-related changes to BC morbidity and mortality on related life and critical illness insurance (CII) products; and
- disseminating the findings to a wider community, including academic and industry parties.
The project outputs will be submitted for publication in leading international research journals, while also being presented at international conferences and seminars.
